Page 7 - Atul Mathur News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Atul mathur. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Atul Mathur Today - Breaking & Trending Today

Inclisiran for cholesterol: Docs call it expensive, bat for cheaper options

Even as India is set to soon launch promising new DCGI and US FDA-approved medicine Inclisiran to lower cholesterol and keep it low with just two doses a year, doctors, while hailing the advance, contend that the drug is expensive and stressed . ....

United Kingdom , Tamil Nadu , New Delhi , Vivek Chaturvedi , Ashwani Mehta , Department Of Cardiology , Indian Council , Cath Lab , Madras Diabetes Research Foundation , Drug Controller General , Amrita Hospital , Atul Mathur , Executive Director Interventional Cardiology , Fortis Escorts Hospital , Medical Research , Senior Cardiologist , Sir Ganga Ram Hospital ,

Inclisiran For Cholesterol: Docs Call It Expensive, Bat For Cheaper Options (Lead)

New Delhi, Jan 14 (IANS) Even as India is set to soon launch promising new DCGI and US FDA-approved medicine Inclisiran to lower cholesterol and keep it low ....

United Kingdom , Tamil Nadu , New Delhi , Vivek Chaturvedi , Ashwani Mehta , Indian Council , Cath Lab , Madras Diabetes Research Foundation , Department Of Cardiology , Drug Controller General , Amrita Hospital , Atul Mathur , Executive Director Interventional Cardiology , Fortis Escorts Hospital , Medical Research , Senior Cardiologist , Sir Ganga Ram Hospital ,

Inclisiran for cholesterol: Docs call it expensive, stress for cheaper options

Even as India is set to soon launch promising new medicine called the DCGI and US FDA-approved Inclisiran to lower cholesterol and keep it low with just two doses a year, doctors while hailing the advance contend that the drug is expensive and . ....

Tamil Nadu , New Delhi , United Kingdom , Vivek Chaturvedi , Ashwani Mehta , Cath Lab , Department Of Cardiology , Indian Council , Madras Diabetes Research Foundation , Drug Controller General , Amrita Hospital , Atul Mathur , Executive Director Interventional Cardiology , Fortis Escorts Hospital , Medical Research , Senior Cardiologist , Sir Ganga Ram Hospital ,

INCLISIRAN FOR CHOLESTEROL | Docs call it expensive, bat for cheaper options

INCLISIRAN FOR CHOLESTEROL | Docs call it expensive, bat for cheaper options
greaterkashmir.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from greaterkashmir.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , New Delhi , Vivek Chaturvedi , Department Of Cardiology , Cath Lab , Drug Controller General , Amrita Hospital , Atul Mathur , Executive Director Interventional Cardiology , Fortis Escorts Hospital ,

Inclisiran for cholesterol: Docs call it expensive, bat for cheaper options

Even as India is set to soon launch promising new DCGI and US FDA-approved medicine Inclisiran to lower cholesterol and keep it low with just two doses a year, doctors, while hailing the advance, contend that the drug is expensive and stressed on better use of the much cheaper versions available. ....

Tamil Nadu , New Delhi , United Kingdom , Vivek Chaturvedi , Ashwani Mehta , Cath Lab , Madras Diabetes Research Foundation , Department Of Cardiology , Indian Council , Drug Controller General , Amrita Hospital , Representational Picture , Atul Mathur , Executive Director Interventional Cardiology , Fortis Escorts Hospital , Medical Research , Senior Cardiologist , Sir Ganga Ram Hospital ,